A potentially disease-modifying therapy for osteoarthritis has reached a key milestone now that a U.S. patent has been issued for FX201, a gene-therapy product candidate based on work led by Baylor researchers.
About 54 million Americans have low bone mass, putting them at risk of developing osteoporosis. During National Osteoporosis Awareness Month, Dr. Brendan Lee explains the causes and risk factors of osteoporosis.
This holiday season, planning ahead can help you establish a workout routine so you can enjoy your favorite holiday treats with less guilt. Dr. Theodore Shybut says to start now and offers safety tips to help avoid injury.
In sports it’s said that the best offense is a good defense, and that can be true for falls too – two orthopedic surgeons offer prevention tips and discuss common injuries that can occur when people fall.
Researchers at Baylor College of Medicine have identified a potential strategy for treating osteoarthritis from both a symptomatic and disease-modifying perspective by using gene therapy to inhibit the interleukin-1 pathway.